{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:20:19Z","timestamp":1784262019814,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1124\/mol.110.070508","type":"journal-article","created":{"date-parts":[[2011,3,4]],"date-time":"2011-03-04T04:00:17Z","timestamp":1299211217000},"page":"910-920","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor"],"prefix":"10.1016","volume":"79","author":[{"given":"Terrance D.","family":"Barrett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather L.","family":"Palomino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa I.","family":"Brondstetter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimon C.","family":"Kanelakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter V.","family":"Haug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet C.","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Thao","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hariharan","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark D.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillary M.","family":"Peltier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kia","family":"Sepassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele C.","family":"Rizzolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Bembenek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Mirzadegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Rabinowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel P.","family":"Shankley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.110.070508_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bcmd.2007.07.017","article-title":"Disturbance in the HIF-1alpha pathway associated with erythrocytosis: further evidences brought by frameshift and nonsense mutations in the prolyl hydroxylase domain protein 2 (PHD2) gene","volume":"40","author":"Al-Sheikh","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1124\/mol.110.070508_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood-2007-12-077388","article-title":"Forging a field: the golden age of iron biology","volume":"112","author":"Andrews","year":"2008","journal-title":"Blood"},{"key":"10.1124\/mol.110.070508_bib3","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","article-title":"HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia","volume":"22","author":"Berra","year":"2003","journal-title":"EMBO J"},{"key":"10.1124\/mol.110.070508_bib4","doi-asserted-by":"crossref","first-page":"C1354","DOI":"10.1152\/ajpcell.1995.268.6.C1354","article-title":"Transport of iron and other transition metals into cells as revealed by a fluorescent probe","volume":"268","author":"Breuer","year":"1995","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.110.070508_bib5","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify HIF","volume":"294","author":"Bruick","year":"2001","journal-title":"Science"},{"key":"10.1124\/mol.110.070508_bib6","doi-asserted-by":"crossref","first-page":"34056","DOI":"10.1074\/jbc.M603913200","article-title":"Clioquinol, a Cu(II)\/Zn(II) chelator, inhibits both ubiquitination and asparagine hydroxylation of hypoxia-inducible factor-1alpha, leading to expression of vascular endothelial growth factor and erythropoietin in normoxic cells","volume":"281","author":"Choi","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.070508_bib7","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/S0301-472X(01)00723-8","article-title":"Novel erythropoiesis stimulating protein (darbepoetin alfa) alleviates anemia associated with chronic inflammatory disease in a rodent model","volume":"29","author":"Coccia","year":"2001","journal-title":"Exp Hematol"},{"key":"10.1124\/mol.110.070508_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/j.gastro.2007.10.012","article-title":"The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis","volume":"134","author":"Cummins","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.110.070508_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ab.2008.09.052","article-title":"Kinetic characterization and identification of a novel inhibitor of hypoxia-inducible factor prolyl hydroxylase 2 using a time-resolved fluorescence resonance energy transfer-based assay technology","volume":"384","author":"Dao","year":"2009","journal-title":"Anal Biochem"},{"key":"10.1124\/mol.110.070508_bib10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(01)00507-4","article-title":"C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation","volume":"107","author":"Epstein","year":"2001","journal-title":"Cell"},{"key":"10.1124\/mol.110.070508_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1124\/mol.110.070508_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1124\/mol.110.070508_bib13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/1087057109333976","article-title":"Characterization of a robust enzymatic assay for inhibitors of 2-oxoglutarate-dependent hydroxylases","volume":"14","author":"Kanelakis","year":"2009","journal-title":"J Biomol Screen"},{"key":"10.1124\/mol.110.070508_bib14","first-page":"548A","article-title":"Effect of FG-2216 on anemia and iron transport in a rat model of anemia of chronic disease (Abstract)","volume":"15","author":"Langsetmo","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/mol.110.070508_bib15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1096\/fj.02-0586fje","article-title":"The antimycotic ciclopirox olamine induces HIF-1alpha stability, VEGF expression, and angiogenesis","volume":"17","author":"Linden","year":"2003","journal-title":"FASEB J"},{"key":"10.1124\/mol.110.070508_bib16","doi-asserted-by":"crossref","first-page":"9814","DOI":"10.1073\/pnas.0601283103","article-title":"Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2)","volume":"103","author":"McDonough","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.070508_bib17","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.1192811","article-title":"Reactivation of hepatic EPO synthesis in mice after PHD loss","volume":"329","author":"Minamishima","year":"2010","journal-title":"Science"},{"key":"10.1124\/mol.110.070508_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0268-960X(98)90022-4","article-title":"Developmental biology of erythropoiesis","volume":"12","author":"Palis","year":"1998","journal-title":"Blood Rev"},{"key":"10.1124\/mol.110.070508_bib19","doi-asserted-by":"crossref","first-page":"11165","DOI":"10.1021\/bi801624f","article-title":"Biochemical characterization of human prolyl hydroxylase domain protein 2 variants associated with erythrocytosis","volume":"47","author":"Pappalardi","year":"2008","journal-title":"Biochemistry"},{"key":"10.1124\/mol.110.070508_bib20","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1182\/blood-2007-04-084434","article-title":"A novel erythrocytosis-associated PHD2 mutation suggests the location of a HIF binding groove","volume":"110","author":"Percy","year":"2007","journal-title":"Blood"},{"key":"10.1124\/mol.110.070508_bib21","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1073\/pnas.0508423103","article-title":"A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis","volume":"103","author":"Percy","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.070508_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2007.09.033","article-title":"Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition","volume":"134","author":"Robinson","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1124\/mol.110.070508_bib23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1021\/ml100198y","article-title":"Benzimidazole-2-pyrazole HIF prolyl 4-hydroxylase inhibitors as oral erythropoietin secretagogues","volume":"1","author":"Rosen","year":"2010","journal-title":"ACS Med Chem Lett"},{"key":"10.1124\/mol.110.070508_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1073\/pnas.0509459103","article-title":"Mouse model for noninvasive imaging of HIF prolyl hydroxylase activity: assessment of an oral agent that stimulates erythropoietin production","volume":"103","author":"Safran","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.070508_bib25","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1128\/iai.57.4.1177-1185.1989","article-title":"Protracted anemia associated with chronic, relapsing systemic inflammation induced by arthropathic peptidoglycan-polysaccharide polymers in rats","volume":"57","author":"Sartor","year":"1989","journal-title":"Infect Immun"},{"key":"10.1124\/mol.110.070508_bib26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/mol.110.070508_bib27","first-page":"5447","article-title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation","volume":"12","author":"Semenza","year":"1992","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.110.070508_bib28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.chembiol.2010.03.008","article-title":"Utilization of an in vivo reporter for high throughput identification of branched small molecule regulators of hypoxic adaptation","volume":"17","author":"Smirnova","year":"2010","journal-title":"Chem Biol"},{"key":"10.1124\/mol.110.070508_bib29","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1182\/blood-2007-09-114561","article-title":"Regulation of adult erythropoiesis by prolyl hydroxylase domain proteins","volume":"111","author":"Takeda","year":"2008","journal-title":"Blood"},{"key":"10.1124\/mol.110.070508_bib30","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.107.701516","article-title":"Essential role for prolyl hydroxylase domain protein 2 in oxygen homeostasis of the adult vascular system","volume":"116","author":"Takeda","year":"2007","journal-title":"Circulation"},{"key":"10.1124\/mol.110.070508_bib31","doi-asserted-by":"crossref","first-page":"8336","DOI":"10.1128\/MCB.00425-06","article-title":"Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2","volume":"26","author":"Takeda","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1124\/mol.110.070508_bib32","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1016\/j.bmcl.2008.06.031","article-title":"Discovery of novel hydroxy-thiazoles as HIF-alpha prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation","volume":"18","author":"Tegley","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.110.070508_bib33","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1096\/fj.02-1062fje","article-title":"Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors","volume":"17","author":"Warnecke","year":"2003","journal-title":"FASEB J"},{"key":"10.1124\/mol.110.070508_bib34","doi-asserted-by":"crossref","first-page":"5687","DOI":"10.1016\/j.bmcl.2006.08.017","article-title":"Design and synthesis of a series of novel pyrazolopyridines as HIF-1alpha prolyl hydroxylase inhibitors","volume":"16","author":"Warshakoon","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.110.070508_bib35","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1016\/j.bmcl.2006.08.089","article-title":"A novel series of imidazo[1,2-a]pyridine derivatives as HIF-1alpha prolyl hydroxylase inhibitors","volume":"16","author":"Warshakoon","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.110.070508_bib36","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1016\/j.bmcl.2006.08.040","article-title":"Structure-based design, synthesis, and SAR evaluation of a new series of 8-hydroxyquinolines as HIF-1alpha prolyl hydroxylase inhibitors","volume":"16","author":"Warshakoon","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.110.070508_bib37","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1016\/j.bmcl.2006.08.026","article-title":"Design and synthesis of substituted pyridine derivatives as HIF-1alpha prolyl hydroxylase inhibitors","volume":"16","author":"Warshakoon","year":"2006","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24029705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24029705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.110.070508","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:51:54Z","timestamp":1739958714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24029705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0026895X24029705"],"URL":"https:\/\/doi.org\/10.1124\/mol.110.070508","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological Characterization of 1-(5-Chloro-6-(trifluoromethoxy)-1H-benzoimidazol-2-yl)-1H-pyrazole-4-carboxylic Acid (JNJ-42041935), a Potent and Selective Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.110.070508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}